ZELINGER JOSEF
Transaction: 07/05/2023
BUY
Change
+15,000,000
Price
$0.01
Filing
08/23/2023
Type
BUY
Propanc Biopharma, Inc.
PPCB • Biotechnology
$1.01
▼ -0.01 (-0.98%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$906,069.99
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 1.5Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.01
Change-0.98%
Shares Out897.10K
Market Cap$906.07K
Enterprise Value$2.01M
Beta3.29
P/E-0.05
P/B0.09
P/FCF-0.22
EV/EBITDA-0.11
EV/FCF-0.49
FCF Yield-453.96%
Price$1.01
Change-0.98%
Shares Out897.10K
Market Cap$906.07K
Enterprise Value$2.01M
Beta3.29
P/E-0.05
P/B0.09
P/FCF-0.22
EV/EBITDA-0.11
EV/FCF-0.49
FCF Yield-453.96%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.12
Current Ratio1.50
Quick Ratio1.50
Volume25.02K
Avg Volume133.63K
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 1.5Weak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
ZELINGER JOSEF
Transaction: 08/17/2021
SELL
Change
0
Price
Not reported
Filing
08/20/2021
Type
SELL
Nathanielsz James Andrew
Transaction: 08/17/2021
BUY
Change
+2,800,000
Price
Not reported
Filing
08/20/2021
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| ZELINGER JOSEF | BUY | +15,000,000 | $0.01 | 07/05/2023 | 08/23/2023 |
| ZELINGER JOSEF | SELL | 0 | Not reported | 08/17/2021 | 08/20/2021 |
| Nathanielsz James Andrew | BUY | +2,800,000 | Not reported | 08/17/2021 | 08/20/2021 |
| Kenyon Julian Norman | BUY | +3,420,000 | Not reported | 08/17/2021 | 08/20/2021 |
| Campiciano Carlo M | OTHER | 0 | Not reported | 06/24/2019 | 06/28/2019 |
| Kenyon Julian Norman | BUY | +9,750,000 | Not reported | 05/14/2019 | 05/22/2019 |
| Kenyon Julian Norman | BUY | +9,750,000 | $0.01 | 05/14/2019 | 05/22/2019 |
| Nathanielsz James Andrew | BUY | +19,500,000 | Not reported | 05/14/2019 | 05/17/2019 |
| Nathanielsz James Andrew | BUY | +19,500,000 | $0.01 | 05/14/2019 | 05/17/2019 |
| Kenyon Julian Norman | BUY | +71,500,000 | $0.03 | 04/14/2016 | 09/27/2016 |
| Nathanielsz James Andrew | BUY | +71,500,000 | $0.03 | 04/14/2016 | 09/27/2016 |
| Kenyon Julian Norman | BUY | +17,654,470 | $17654.00 | 02/04/2015 | 09/27/2016 |
| Nathanielsz James Andrew | BUY | +33,259,350 | $33259.00 | 02/04/2015 | 09/27/2016 |
| Nathanielsz James Andrew | BUY | +500,000 | Not reported | 11/09/2014 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -55,000 | $0.09 | 07/05/2013 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -15,000 | $0.20 | 01/23/2013 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -5,500 | $0.20 | 12/13/2012 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -5,000 | $0.20 | 09/14/2012 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -250,000 | $0.20 | 09/04/2012 | 01/13/2015 |
| Nathanielsz James Andrew | SELL | -250,000 | $0.20 | 08/23/2012 | 08/24/2012 |